Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GSPT2 (GTP-binding protein GSPT2), also known as eukaryotic peptide chain release factor GTP-binding subunit ERF3B, is a protein that functions primarily as a polypeptide release factor involved in translation termination. It acts as a component of the eRF1-eRF3-GTP ternary complex, which mediates translation termination at stop codons. It may also play additional roles in mRNA stability regulation and cell cycle progression. It is highly expressed in certain cancers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic peptide chain release factor GTP-binding subunit ERF3B (GSPT2).